Últimos testes

EudraCT Number: 2009-013706-13

Sponsor Protocol Number: TOP_LID_DPNP

Start Date:

Sponsor Name: Wilhelminenspital der Stadt Wien

Full Title: ANALGESIC RESPONSE TO TRANSDERMAL LIDOCAINE IN PATIENTS WITH PAINFUL PERIPHERAL DIABETIC NEUROPATHY UNDERLYING DIFFERENT SENSORY PATTERNS

Medical condition: In this study the effect of transdermal lidocaine in patients with painful peripheral diabetic neuropathy will be examined.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: (No results available)

EudraCT Number: 2008-001519-39

Sponsor Protocol Number: 2008-02-12-1

Start Date:

Sponsor Name: Biologiske Stasjon Drøbak

Full Title: Efficiency of a jellyfish sting inhibitor sun lotion and protocols for jellyfish sting pain relief

Medical condition: The degree of pain reduction in test subjects using a specific jellyfish (cnidaria) sting inhibitor and repellent lotion, compared to control subjects being protected by a normal water repellent su...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: NO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-003621-10

Sponsor Protocol Number: IC2011.05

Start Date:

Sponsor Name: INSTITUT CURIE

Full Title: CONSERVATIVE TREATMENT OF PATIENTS WITH RETINOBLASTOMA

Medical condition: RETINOBLASTOMA

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10010331 - Congenital, familial and genetic disorders	10038918	Retinoblastoma NOS	LLT

Population Age: Newborns, Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-011881-27

Sponsor Protocol Number: ADAM

Start Date:

Sponsor Name: University Medical Center of the Johannes Gutenberg-University Mainz

Full Title: Changes of cerebral spinal fluid APPSα levels under oral therapy with acitretin 30 mg daily in patients with mild to moderate Alzheimer’s disease: a multicenter prospective randomised placebo-contr...

Medical condition: Alzheimer’s disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029205 - Nervous system disorders	10001896	Alzheimer's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2009-015642-35

Sponsor Protocol Number: POVO-2009

Start Date:

Sponsor Name: medphano Arzneimittel GmbH

Full Title: Doppelblinde, randomisierte, kontrollierte, klinisch-experimentelle Studie der Phase II zum Nachweis der Wirksamkeit mittels Vasokonstriktionstest von Polcortolon® N Spray gegenüber Volonimat® Salb...

Medical condition: healthy volunteers.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2005-001559-39

Sponsor Protocol Number: 01/2005_01

Start Date:

Sponsor Name: Charité-Campus Mitte und Campus Virchow-Klinikum

Full Title: Randomisierte Phase II Studie zum Vergleich einer wöchentlichen Topotecangabe mit der Topotecangabe an fünf aufeinander folgenden Tagen bei Patientinnen mit platinresistentem rezidiviertem epitheli...

Medical condition: Patientinnen mit Ovarialkarzinom und Rezidiv / Progress

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2012-005226-29

Sponsor Protocol Number: IBD-0337

Start Date:

Sponsor Name: Wolfson Medical Center

Full Title: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

Medical condition: Crohn's disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: NL (Ongoing) BE (Ongoing) PL (Completed) PT (Completed)

Trial results: (No results available)

EudraCT Number: 2022-002787-68

Sponsor Protocol Number: IMVT-1401-3201

Start Date:

Sponsor Name: Immunovant Sciences, GmbH

Full Title: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)

Medical condition: Thyroid Eye Disease (TED)

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	100000004853	10084358	Thyroid eye disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) IT (Ongoing) PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-004540-31

Sponsor Protocol Number: Theophyllin_2

Start Date:

Sponsor Name: Universitätsklinikum Tübingen

Full Title: Monozentrische, randomisierte, placebo-kontrollierte Studie zur Evaluation der Nephroprotektion durch Theophyllin unter Cisplatin-haltiger Chemotherapie

Medical condition: evaluation of the nephroprotective efficacy of oral theophylline in patients treated with cisplatin

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2018-004058-11

Sponsor Protocol Number: RM-493-023

Start Date:

Sponsor Name: Rhythm Pharmaceuticals, Inc.

Full Title: A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity

Medical condition: Obesity and hyperphagia in patients with Bardet-Biedl Syndrome or Alström syndrome

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Completed) ES (Completed) GB (GB - no longer in EU/EEA)

Trial results: View results

Últimos testes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas